Your cookie preferences

We store cookies on your device to make this website work. We would also like to use analytics cookies. These collect and send information about how our site is used to services such as Google Analytics. We use this information to improve our site. If you accept these additional cookies, a cookie will be stored to save your choice. You can update your consent to using these cookies at any time.

Cookie types explained
  • Essential: Essential cookies enable basic functionality and are necessary for the website to work properly.
  • Analytics: Analytic cookies collect information anonymously. This information helps us to understand how our visitors use our website.

PGD, PGS and CGH Treatments

  • PGD - Pre-implantation genetic diagnosis enables people with an inheritable condition in their family to avoid passing it on to their children. It involves checking the genes and/or chromosomes of embryos created through IVF to exclude affected embryos.
  • PGS - Pre-implantation genetic screening (also known as aneuploidy screening) involves checking the chromosomes of embryos conceived by IVF or ICSI for common abnormalities. Chromosomal abnormalities are a major cause of the failure of embryos to implant and of miscarriages. They can also cause conditions such as Down's syndrome.
  • CGH - is an emerging form of preimplantation genetic screening (PGS) that is used to detect abnormalities in the number of chromosomes in an egg or an embryo.